How Do Newer Antidiabetic Drugs Lower Stroke Risk?

Studies suggest that lower stroke risk associated with newer antidiabetic therapies is not due to the drugs' tighter glycemic control. So, what is the mechanism?

Related Keywords

Shawnee ,Kansas ,United States ,University Of Kentucky ,Kentucky ,Denver ,Colorado ,American ,Gordon Kelley ,Larryb Goldstein ,University Of Kentucky College Medicine ,American College Of Cardiology Heart Association ,Shawnee Mission ,Adventhealth Medical Group ,Meeting Of The American Academy Neurology ,Kentucky College ,Annual Meeting ,American Academy ,Stroke Treatment ,Pharmacy Journal ,American Heart Association ,Primary Prevention ,Cardiovascular Disease ,Stroke Cerebrovascular Accident Cva ,Weight Loss ,Stroke Risk ,Diabetes Mellitus Type 2 ,Iabetes Mellitus Type Ii ,Type 2 Diabetes ,Ype 2 Dm ,T2dm ,2d ,Glp 1 Receptor Agonists ,Glucagon Like Peptide 1 Receptor Agonists ,Clinical Guidelines ,Guidelines ,Atherosclerotic Heart Disease ,Therosclerotic Cardiovascular Disease ,Oronary Heart Disease ,Schemic Heart Disease ,